Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Enrolling by Invitation

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

NCT05669989

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Washington University- Site Number : 8400001 St Louis, Missouri, United States
  • Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
  • Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
View all 37 locations
View Trial Details
Enrolling by Invitation

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

NCT06723106

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Campbelltown Public Hospital Sydney, New South Wales, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
View all 62 locations
View Trial Details
Enrolling by Invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Chiba university hospital_Pediatrics Chiba, Japan
  • National Hospital Organization Awara Hospital_Hematology and Oncology Fukui, Japan
  • Hoshi General Hospital_Pediatrics Fukushima, Japan
  • Hyogo Prefectural Amagasaki General Medical Center_Haematology Hyōgo, Japan
View all 23 locations
View Trial Details
Enrolling by Invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Novo Nordisk Investigational Site Toshima City, Tokyo, Japan
  • Mutsu general hospital_Pediatrics Aomori, Japan
  • Kyushu university hospital_Pediatrics Fukuoka, Japan
  • Sapporo Tokushukai Hospital_Pediatrics Hokkaido, Japan
View Trial Details
Enrolling by Invitation

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

NCT03745924

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • AKH - Klin. Abt. f. Haematologie u. Haemostaseologie Vienna, Austria
  • Cliniques universitaires Saint-Luc - Service Hématologie Brussels, Belgium
  • UZ Antwerpen - UZA - Kinderhemato-Oncologie Edegem, Belgium
  • UZ Leuven - Hart en Vaatziekten Leuven, Belgium
View all 30 locations
View Trial Details
Enrolling by Invitation

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

NCT05997914

Conditions
Adherence, Medication, Anticoagulants and Bleeding Disorders, Arrhythmias, Cardiac, +26 more
Locations
  • Luis Ortega Paz Jacksonville, Florida, United States
  • Decentralized Worcester, Massachusetts, United States
  • UMass Chan Medical School Worcester, Massachusetts, United States
  • University of Michigan Medical School Ann Arbor, Michigan, United States
View Trial Details

Related conditions